John Kotter - University of Kentucky

Education/Academic qualification

Residency, University Of Kentucky

2012

Doctor of Medicine, University Of Utah

2009

Bachelor of Science, University Of Utah

2004

6 Active
8 Finished

DAL-302 (dal-GenE-2) Trial: A Phase 3, Double-Blind, Randomized Placebo Controlled Study To Evaluate The Effects Of Dalcetrapib On CV Risk In A Genetically Defined Population With Recent ACS
Kotter, J. (PI)
DalCor Pharmaceuticals Canada Incorporated
4/26/24 → 4/26/26
Project: Research project
REVERXaL- A Multinational Observational Study to Describe The Patient Characteristics and Health Care Data of Patients with Major Bleeding While Taking Blood Thinners
Kotter, J. (PI)
Parexel International LLC
3/24/24 → 3/24/26
Project: Research project
Victorian-2 Prevent: A Randomized Double-Blind, Placebo-Controlled, Multicenter Trial, Assessing The Impact of Inclisiran On Major Adverse Cardiovascular Events In Participants With Established Cardiovascular Disease
Kotter, J. (PI)
Novartis (domestic)
10/27/22 → 9/13/25
Project: Research project
Data-driven Optimization of Therapy for Heart Failure
Campbell, K. (PI), Birks, E. (CoI), Kotter, J. (CoI), Wenk, J. (CoPI) & Vaidya, G. (Former CoI)
National Heart Lung and Blood Institute
5/1/22 → 4/30/26
Project: Research project
PB2452 Phase 3 Ticagrelor Reversal Study (PB2452-PT-CL-0004
Kotter, J. (PI) & Abdel-Latif, A. (Former PI)
SFJ Pharmaceuticals X Ltd
1/7/21 → 8/21/25
Project: Research project

Fellow of the American Society of Echocardiography (FASE)
Kotter, J. (Recipient), 2021
Prize: Honorary award